Traws Pharma, Inc. is a clinical-stage biopharmaceutical company based in Newtown, Pennsylvania, dedicated to advancing innovative therapies for cancer treatment in the United States. With a robust pipeline of novel products, Traws leverages cutting-edge research and development to address unmet medical needs in oncology. The company's commitment to improving patient outcomes positions it as a key player in the evolving landscape of cancer therapeutics, making it an attractive prospect for institutional investors seeking exposure to the biopharmaceutical sector.
Click "Analyze" to generate stock analysis
TRAW Price Trend and Signals
TRAW Financials
2025-10-23Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.